irritable bowel syndrome a functional or an organic condition? ferrara, september 27 th , 2014

35
Irritable Bowel Syndrome A functional or an organic condition? Ferrara, September 27 th , 2014 Reinhold W. Stockbrugger Em. Prof. Gastroenterology and Hepatology, University Maastricht/NL Contract Prof. Internal Medicine, University Ferrara/I Editor European Journal of Gastroenterology & Hepatology [email protected]

Upload: genevieve-harris

Post on 15-Mar-2016

27 views

Category:

Documents


1 download

DESCRIPTION

Irritable Bowel Syndrome A functional or an organic condition? Ferrara, September 27 th , 2014. Reinhold W. Stockbrugger Em . Prof. Gastroenterology and Hepatology , University Maastricht/NL Contract Prof. Internal Medicine, University Ferrara/I - PowerPoint PPT Presentation

TRANSCRIPT

  • Irritable Bowel SyndromeA functional or an organic condition?Ferrara, September 27th, 2014Reinhold W. StockbruggerEm. Prof. Gastroenterology and Hepatology, University Maastricht/NLContract Prof. Internal Medicine, University Ferrara/IEditor European Journal of Gastroenterology & Hepatology

    [email protected]

  • What is a functional condition?? I do not function ?? It functions me ?? Am I healthy ?? Sick leave for functional disorders ?? Do I need a psychologist ?? Or a pension ?? Why has the doctor said that that (s)he cannot help me? I think (s)he does not function !!!

  • RS: body + soul?Fortunately much more!My parents (or the lack of them)The alcoholThe politicsThe bugsMy bossThe weatherThe fast and slow foodThe sexThe moneyThe musicThe diabetesThe sportsThe future and the anxiety

  • IBS Critical Review 2014

    epidemiology

    etiology, pathogenesis

    clinical presentation and diagnosis

    treatment

    outcome

    future needs

  • The IBS Manual, 1999Copyright 1999 Harcourt Publishers Limited

    Prevalence of IBS in community-based populations

    Fig 2.4

  • IBS EpidemiologyIn Northern GreeceKatsinelos et al. Eur J Gastroenterol Hepatol 2009; 21: 183-9

    Setting: Primary Care, 2004 - 2007N= 2397 (f: 70.6%; mean age 46.1 years)

    IBS in 15.7% (D-IBS 36.5%; C-IBS 44.2%; M-IBS 19.3%)

    IBS patients more likely to be:femalefrom urban areas

  • IBS EpidemiologyIn Asia

    Gwee et al. J Gastroenterol Hepatol 2009; 24: 1601-7

    Early studies: prevalence

  • IBSEtiology, pathogenesisThe times, they are changing

    1980 Motility1990 Psychology2000 Microbiology Neurophysiology2009Motility, Metabolism, Diet2014FODMAPs (Fermentable Oligosaccharides Disaccharides Monosaccharaides And Polyols)

  • The Newcomer: FODMAPsA diet low in FODMAPs reduces symptoms of Irritable Bowel SyndromeHalmos E.P. et al. Gastroenterology 2014; 146: 67 75

    High FODMAP food (things to avoid / reduce)Vegetables and LegumesGarlic avoid entirely if possibleOnions avoid entirely if possibleArtichokeAsparagusBaked beansBeetrootBlack eyed peas For this you really could need a dietician!Broad beansButter beans CauliflowerCelery greater than 5cm of stalkKidney beansLeeksMange ToutMushroomsPeasFruit fruits can contain high fructose + other 121 items!ApplesApricotsAvocadoBlackberriesCherriesCurrantsDatesGrapefruitLycheeMangoNectarinesPeachesPearsPersimmonPlumsPrunesRaisinsTinned fruit in apple / pear juiceWatermelonCereals, Grains, Breads, Biscuits, Pasta, Nuts and CakesWheat containing products such (be sure to check labels):BiscuitsBreadcrumbsCashewsCakesEgg noodlesRegular noodlesPastriesPasta made from wheatUdon noodlesWheat breadWheat cerealsWheat rollsBarleyBran cerealsCouscousPistachiosRyeSemolinaSweets, Sweeteners and SpreadsAgavaeFructoseHigh fructose corn syrup (HFCS)HoneyMilk chocolateSugar free sweetsInulinIsomaltMaltitolMannitolSorbitolXylitolPrebiotic FoodsThe follow items can be added to yoghurts, snack bars etc:FOS fructooligosaccharidesInulinOligofructoseDrinksBeer if drinking more than one bottleDandelion teaFruit and herbal teas with apple addedOrange juice in quantities over 100mlRumSugar free fizzy drinks such as diet cokeSports drinksWine if drinking more than one glassDairy FoodsButtermilkCream cheeseCreamCustardIce creamMargarineMilk cow, goat and sheepSour creamYoghurt including greek yogurt

  • Diet and IBS

    Fig 6.3

  • COLONIC FERMENTATION

    Hypothesis: Is over-eating one further cause of increasing IBS in the wealthy part of the Western world?

    Entrez PubMed: irritable bowel syndrome + diet: 150 hits

    www.google.com: irritable bowel syndrome + diet: 46.100 hits

  • A pleasant Limburgian gentleman!

    Mr. Alphonse de X., date of birth 1934, a retired official of the Limburgian provincial government is happily married and calls himself a gourmet. He consults 1/1999: occasional nausea, abdominal cramping, heartburn, intermittend diarrhoea of watery to porridgy consistency with urgency

    Previous history: Guillain-Barres disease, completely recovered. 1987 possible cardiac infarction; stopped smoking at a weight of 82 kg at a length of 1.84 m (BMI 24.2). After that (and retirement!) weight increase to 102 kg. Family history: CRC in 2 first-degree relatives; several colonoscopies without pathological findings

    Examination: BMI 30.1; 102 kg; serum triglycerides 2.37 mmol/l.

    What does Alphonse suffer from? What diagnostic steps are You taking?

  • 72-hour faecal collection some days later:

    faecal mass (g)312428157

    faecal fat (g)65.3 per 72 hours

    chymotrypsin U/g19.840.220.1

    osmotic gap (mosmol/kg)150240 64

    Your diagnosis? Your treatment?

  • Alphonse, two years after: no symptoms, 94 kg = BMI 27.7

    72-hour faecal collection 12/2000

    faecal mass (g):144212 222

    faecal fat (g):25 g per 72 hours

    chymotrypsin (U/g)18.417.6 16.4

    osmotic gap (mosmol/kg) 00 18

    Au revoir, Alphonse?

  • Post-infectious IBS7-30 % of patients with a proven bacterial gastroenteritis will develop IBS. Definition:PI-IBS is an acute Rome II criteria positive IBS developing after an infectious illness, characterised by two or more of the following:

    -fever-vomiting-acute diarrhoea-positive stool culturePI-IBS: clinically distinct subgroup characterized by more diarrheal symptoms, less psychiatric illness, and increased serotonin-containing Enterochromaffin cells (EC cells) compared to those with nonPI-IBS.

    unlike most other IBS there is a clearly defined start date

  • The pathogenesis of post-infectious Irritable Bowel Syndrome:

    Inflammation increased production of serotonin by EC cells impairment of expression of SERT impaired clearance of serotonin from the gut

    Consequences:- enhanced motility- increased intestinal permeability- increased sensitivity

    Gut. 2002 Sep;51(3):410-3.Prognosis in post-infective irritable bowel syndrome: a six year follow up study.Neal KR, Barker L, Spiller RC.

  • IBS and the diagnosispositive diagnostic criteriavs.exclusion diagnosis?

    WRONG QUESTION:DIAGNOSIS IS ABOUT PROBABILITIES!

  • Twelve key clinical questions have been suggested by Drossman to be asked during a first consultation to help to determine the nature of the condition and to help plan management. These include questions about the type of pain experienced by the patient and its history, the patients understanding of the illness, and the possible involvement of psychological and psychosocial factors. Other questions to be asked include the effect the disorder is having on the daily physical, psychological, and social activity of the patient and the reason for the patients visit or referral.Reasons for the visit may include a worsening of functional status or new circumstances exacerbating the condition e.g. a change in diet or a concurrent medical disorder; concerns about having a serious disease; stress-related factors; a psychiatric co-morbidity such as depression or anxiety; impaired daily function e.g. recent inability to work or to socialise; a hidden agenda e.g. laxative abuse, to obtain narcotics, to gain disability benefits or the justification of illness to family or co-workers; or any combination of these. The physician may also have to consider referral, perhaps because a colonoscopy or other procedure is required to complete an evaluation or because additional assessments are needed (e.g. psychological or psychiatric).

    References:Drossman DA. Diagnosing and treating patients with refractory functional gastrointestinal disorders. Ann Intern Med 1995; 123: 688-97.Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: A technical review for practice guideline development. Gastroenterology 1997; 112: 2120-37.

  • MY WAY:

    The IBS Manual, 1999Copyright 1999 Harcourt Publishers Limited

    Time heals everything

    Fig 1.12

  • IBSClinical presentation and diagnosisTo consider (depending on history, physical and mental examination, basic lab, and environment):

    Postinfectious IBS (onset!)Lactose intoleranceOther nutritional causes (fructose, BMI)Chronic parasitic infectionInflammatory Bowel DiseaseEarly childhood traumaPsychosocial stress/events (chronic > acute)

  • IBSClinical diagnosisUseless:

    Genetic testingExplorative allergy testingExtended microbiology of the faecesSophisticated motility tests (barostat)Primary psychiatry consultation

  • IBSClinical presentation and diagnosisUseful:

    - Comorbidity (fibromyalgia; dyspepsia; dysuria; etc)- Assessment anxiety and depression (HADS)- Assessment Health-Related Quality of Life (HRQoL)

  • Relation between concurrent anxiety and/or depression and SF-36Mean scoreSF-36 subscales

    Grafiek3

    82.05178.52970.341

    68.84658.40328.409

    58.08753.15146.258

    65.63555.26942.33

    63.35951.38734.831

    80.70567.96250.843

    86.49669.11826.136

    78.52361.79842.292

    A0D0

    A1D0

    A1D1

    Blad1

    PFRPBPGHVTSFREMH

    A0D082.05168.84658.08765.63563.35980.70586.49678.523

    A1D078.52958.40353.15155.26951.38767.96269.11861.798

    A1D170.34128.40946.25842.3334.83150.84326.13642.292

    Blad1

    000

    000

    000

    000

    000

    000

    000

    000

    A0D0

    A1D0

    A1D1

    Blad2

    Blad3

  • IBSTreatmentIs there a standard treatment for IBS?

    NO (and YES)

  • Overlap FD and IBS

    Therapy: the SCEPT concept

    Sincerity Compassion Education Patience Time

  • IBSTreatment, some progress (1) Bijkerk et al. BMJ 2009; 339: b3154

    Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial

    Setting: General practice, NetherlandsN= 275Treatment: psyllium 10 g or bran 10 g or placebo 10 gOutcome: psyllium better than both alternatives, with the best symptom reduction after 3 months

  • IBSTreatment, some progress (2)Simren et al. Aliment Pharmacol Ther 2010; 31: 217-27

    Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome, a randomized, double-blind, controlled trial

    Setting: outpatientN= 74Probiotic: 2 lactobacilli, 1 bifidobacter, in acidified milkDuration: 8 weeks; weekly assessmentResponse: probiotic 38%, placebo 27% (n.s.); probiotics better in the initial 2 weeks

  • The last meta-analysisAm J Gastroenterol. 2014 Jul 29. doi: 10.1038/ajg.2014.202. [Epub ahead of print]

    Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis.

    Ford AC1, Quigley EM2, Lacy BE3, Lembo AJ4, Saito YA5, Schiller LR6, Soffer EE7, Spiegel BM8, Moayyedi P9

  • Postinfectious IBSOutcome (1)Good hope:

    Jung et al. J Clin Gastroenterol 2009; 43: 534-40The clinical course of postinfectious irritable bowel syndrome: a five-year follow-up study

    Setting: Hospital personnel; 5 years after Shigella infection outbreak

    N= 119 (Shigella exposed 60; controls 59)

    Follow-up at 1, 3, 5 years

  • Postinfectious IBSOutcome (2)IBS after infection (in %)

    TimeShigella +Shigella

    1 year13,81.1s.

    3 years14.94.5s.

    5 years20.812.2n.s.

  • IBSFuture needs (1)At short term:

    Knowledge about causes and natural history

    Capacity to apply a bio-psycho-social model to diagnosis, therapy and follow-up (SPECT)

    Patient-orientated healthcare organisation

    More public information about functional gastrointestinal disorders and their comorbidity

  • IBSFuture needs (2)At longer term, individualised care:

    Markers for the pathogenetic contribution of Central and Peripheral Nervous System, gut flora and immune system, as well as for the psycho-social risks factors

    Drugs and clinical techniques that can interfere at central, intermediate and/or peripheral levels

  • There is always hope!

  • *********************